Pharmafile Logo
Pharmafocus logo
Advanced Search

Government changes tender regulations

March 6, 2013
Sales and Marketing GPs, NHS, coalition

The government has agreed to alter a key part of the Health and Social Care Act after GPs protested about …

News

UK lag in early deaths

March 5, 2013
Medical Communications, Sales and Marketing Gates, Lancet, UK

The UK is lagging behind other developed nations when it comes to preventing early deaths from a number of diseases, …

News
Hospira image

Hospira woes continue as GSK sues over quality failures

March 5, 2013
Manufacturing and Production GSK, Hospira

The difficulties besetting generic firm and contract manufacturer Hospira have taken a new turn with the news that one of …

News

Nicholson faces down critics

March 5, 2013
Medical Communications, Sales and Marketing Mid Staffs, NHS, Nicholson

Sir David Nicholson, chief executive of the NHS, has been involved in testy exchanges with MPs at the House of …

News

Capsugel cuts deal to buy Scotland’s Encap

March 5, 2013
Manufacturing and Production Capsugel, encap

Capsugel has bought Scotland’s Encap Drug Delivery in yet another bout of merger & acquisition (M&A) activity in the capsule …

News

NHS Commissioning Board appoints new director of Patient Experience

March 4, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CB, Churchill, NHS, UK

The NHS Commissioning Board has appointed Neil Churchill as the director of Patient Experience. In this new role Churchill will ensure that improving patient …

Appointment

IPEC Americas takes aim at atypical visible particles

March 4, 2013
Manufacturing and Production AVP, IPEC Americas

The industry body representing excipient users and suppliers in the US has set up a working group to tackle the …

News

Risk-assessment for excipients: guideline out for comment

March 4, 2013
Manufacturing and Production GMP, risk

The European Commission has published its long-awaited risk-assessment guideline for determining the level of Good Manufacturing Practice (GMP) needed for …

News

EU approval for Ilaris

March 4, 2013
Sales and Marketing Ilaris, Novartis

Novartis’ Ilaris has become the first biologic approved by the European Commission to treat patients suffering acute gouty arthritis attacks …

News
sanofi_hq_reception_close

Zaltrap launched in UK

March 4, 2013
Sales and Marketing Sanofi, Zaltrap

Sanofi and Regeneron Pharmaceuticals’ bowel cancer drug Zaltrap has been launched in the UK today. Zaltrap (aflibercept) will be used …

News

Boehringer targets AML

March 1, 2013
Research and Development, Sales and Marketing AML, Boehringer

Boehringer Ingelheim is to begin a pivotal trial of its investigative treatment volasertib in patients with acute myeloid leukaemia (AML). …

News

Lundbeck booze pill for EU

March 1, 2013
Sales and Marketing Lundbeck, alcohol, selincro

Lundbeck’s novel pill Selincro has been given European marketing authorisation to help patients with a drink problem to cut down. …

News
screen_shot_2013-02-28_at_14

RSA welcomes pan-European consultant

February 28, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing rsa

Life sciences executive search and interim management firm RSA has announced that Dr Theo de Roij has joined the pan-European …

Appointment
Eliquis image

Eliquis approved by NICE

February 28, 2013
Sales and Marketing BMS, Eliquis, NICE, Pfizer

In a move which will cheer Bristol-Myers Squibb and Pfizer, NICE has recommended oral blood-thinner Eliquis for use on the …

News
ABPI image

ABPI moves to improve compliance

February 28, 2013
Sales and Marketing ABPI, NHS, alltrials, goldaccre, whiehead

The ABPI has fired its latest salvo in the clinical trial transparency debate by announcing it will appoint a new …

News
UCB image

UCB warns of data ‘voyeurism’

February 27, 2013
Research and Development, Sales and Marketing EFPIA, UCB, VBP, transparancy

UCB chief executive Roch Doliveux has attacked the idea of making all clinical trial data publicly available, saying it could …

News
Roche image

Roche increases data access

February 27, 2013
Research and Development, Sales and Marketing ABPI, BMJ, Goldacre, Roche

Roche has launched a new process designed to enable greater access to its clinical trial data for researchers from outside …

News
annadixon

The King’s Fund’s Anna Dixon joins Department of Health

February 27, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dixon, NHS, king's fund

Director of Policy at The King’s Fund Dr Anna Dixon will be joining the Department of Health in early May …

Appointment
bad pharma image

Ben Goldacre versus Stephen Whitehead – PharmaTimes Debate

February 27, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BMJ, Bad pharma, Cochrane, Goldacre, Whitehead

In the end, the ‘head to head’ between the UK’s most high profile critic of the pharma industry and ABPI …

Feature
Merck image

Merck suffers brain cancer reverse

February 26, 2013
Sales and Marketing Merck, cilengitide

Merck’s oncology programme has suffered a setback as a Phase III trial of its investigational integrin inhibitor cilengitide failed in …

News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026